Clinical Trial: Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Malignant Solid Neoplasm
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Trial Evaluating the Combination of Temozolomide and the Ataxia Telangiectasia and Rad3-Related Inhibitor M1774
Brief Summary:
This phase I/II trial studies the side effects and best dose of temozolomide and M1774 and how well they works in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) and may have spread to nearby tissue, lymph nodes, or distant parts of the body (advanced).Temozolomide is in a class of medications called alkylating agents.It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill tumor cells and slow down or stop…
Read more